Illumina | Sequencing and array solutions to fuel genomic …
Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.
Illumina, Inc. - Wikipedia
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated …
Careers | Biotech and genomics job opportunities - Illumina
At Illumina, we have the opportunity to do work that transforms human health. Find genomics and biotech jobs at Illumina.
Illumina, Inc. - Illumina and NVIDIA collaborate to decode …
Jan 13, 2025 · Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for …
All Products - Illumina, Inc.
View a complete list of Illumina sequencing and microarray products. Filter by system compatibility and other key features to narrow the list.
25 greatest impacts in 25 years: Illumina and the evolution of …
Apr 3, 2023 · Illumina, a global leader in DNA sequencing and array-based technologies, celebrates its 25th year in business. For our anniversary, we’re counting the ways our …
Company Overview | An innovative genomics company - Illumina…
Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Illumina, Inc. - Investors
A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, …
Illumina, Inc. - Illumina Reports Financial Results for Fourth …
5 days ago · Core Illumina revenue of $1.1 billion for Q4 2024, up 1% from Q4 2023 on both a reported and constant currency basis; revenue of $4.3 billion for fiscal year 2024, down 2% …
Products for Genomics | Illumina
Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.